Clinical Trials
8 trialsNCT06690489 2026-01-12
BCARE
Pierre Fabre Medicament
Completed
NCT00026754 2025-04-18
Eligibility Screening for the NIH Intramural Research Program Clinical Protocols
National Institutes of Health Clinical Center (CC)
Completed
NCT04177108 2024-03-27
A Study of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer
Hoffmann-La Roche
Phase 3 Completed
NCT03924011 2021-09-01
LABRA
Hasselt University
Phase NA Completed
NCT00341692 2020-04-29
Studying Normal Breast Tissue and Cancer Risk
National Institutes of Health Clinical Center (CC)
Completed
NCT01743560 2019-07-18
4EVERUK
Novartis
Phase 4 Completed
NCT00753415 2015-03-17
A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)
Merck Sharp & Dohme LLC
Phase 1 Completed
NCT00050427 2011-04-28
A Study of ET-743 (Trabectedin) in Patients With Advanced Breast Cancer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Phase 2 Completed